Medical Disorders
Resources
Basic InformationLookupsLatest News
Drop in Life Expectancy From COVID Much Worse for Black, Hispanic AmericansInnovative Kidney Donor 'Voucher' System Is Saving LivesMental Confusion an Early Warning Sign of Severe COVID-19COVID Caused Biggest Drop in U.S. Life Expectancy Since World War IIClot-Removing Procedure Can Sometimes Backfire for Stroke PatientsFDA to Add Warning to Pfizer, Moderna Vaccines About Rare Heart Issues in YoungAHA News: Silent Heart Attacks All Too Common, and Often OverlookedRash, Itch After COVID Vaccine Rare & Quickly ResolvesStudy Suggests COVID Vaccine Booster Shots Will Be NeededNo Need for Blood Thinners in Patients Sick at Home With COVID-19Heart Issues in Young COVID Vaccine Recipients Rare, Usually Mild and Quickly Resolve: ExpertsMore E-Scooter Rideshares, More InjuriesMore Than Half of People With Asthma Aren't Seeing a SpecialistAutopsy Study Shows How COVID Harms the BrainCOVID Deaths Drop to New Lows in U.S., While Vaccination Rates ClimbNot-So-Happy-Birthdays: Parties Helped Spread COVID, Study FindsAHA News: Should Rare Cases of Heart Inflammation Put Your COVID-19 Vaccine Plans on Hold?Obesity in Teens Raises Adult Diabetes Risk, Even After Weight LossNew Genetic Insights Into Cause of ALSScreen All Kids for Heart Problems, Pediatricians' Group SaysIn 11 States, Seniors' Low Vaccination Rates a 'Powder Keg' for New CasesSickle Cell Plagues Many Black Americans, But There's Hope for Better TreatmentsSurvivors' Plasma Helps Blood Cancer Patients Battle COVID-19Hospitals: One Reason COVID Is More Lethal for Black AmericansMany 'High Priority' Patients Aren't Getting Put on Kidney Transplant ListsU.S. to Spend $3.2 Billion to Help Develop Antiviral Pills for COVIDRed Cross Warns of Severe Blood ShortageHand Sanitizer Vapors Can Cause Nausea, DizzinessPfizer, Moderna Vaccines Do No Harm to Male Fertility: StudyLess Than 1% of People Who've Had Severe COVID Get Re-InfectedMold a Big Threat to People With COPDWhat Works Best to Ease Migraines?Pandemic Silver Lining: Fewer Dangerous Flare-Ups for COPD PatientsIs Zinc a Friend or Foe to Kidney Stones?Strict Rest Not Recommended After Sports-Linked Concussion, Experts SayEven Good Weather Didn't Lift Lockdown Blues: StudyU.S. ​COVID Death Toll Tops 600,000Third Dose of COVID Vaccine Boosts Protection in Transplant RecipientsCould a Type of Statin Raise Dementia Risks?Many U.S. Seniors May Need Better Knee Arthritis CareAfter COVID, Many Americans Are Struck by New Maladies: StudyCataracts: Common, and Easy to TreatThere Are Many Good Reasons for Kids to Get the COVID VaccineBabies Produce Strong Immune Response to Ward Off COVID-19: StudyNovavax's COVID Vaccine Shines in Latest TrialAHA News: U.S. Appears to Lose Ground in Controlling High Blood PressureWeight-Loss Surgeries Used Least in U.S. States That Need Them MostObesity Could Raise Odds for 'Long-Haul' COVID SymptomsSmokers, Obese People Need Major Heart Interventions Earlier in LifeOld Age No Bar to Successful Heart Transplant, Study Finds
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

AstraZeneca COVID Vaccine Tied to Rare Cases of Low Blood Platelets

HealthDay News
by Robert Preidt
Updated: Jun 9th 2021

new article illustration

WEDNESDAY, June 9, 2021 (HealthDay News) -- The AstraZeneca COVID-19 vaccine may be linked with rare cases of low blood platelet levels, a new study suggests.

Platelets are blood cells that help prevent blood loss when vessels are damaged. Low platelet levels may cause no symptoms, but they can lead to an increased risk of bleeding or clotting.

Researchers analyzed data from 5.4 million people in Scotland, including 2.5 million who had received their first COVID-19 vaccine dose.

They found that people who received the AstraZeneca vaccine had a very small increased risk of a condition called idiopathic thrombocytopenic purpura (ITP), which is characterized by low platelet counts.

The estimated risk was 11 per million doses, similar to rates for hepatitis B, flu and MMR vaccines, which range from 10 to 30 cases of ITP per million doses.

Those at most risk tended to be older -- median age 69 years -- and had at least one underlying chronic health problem such as heart disease, diabetes or chronic kidney disease, the study found.

The researchers found a slight increase in ITP in the second week following vaccination with the AstraZeneca vaccine, along with a possible small increased risk of arterial clotting and bleeding events.

The AstraZeneca vaccine has not been approved for use in the United States. There was no evidence of increased risk of ITP, clotting or bleeding with the Pfizer-BioNTech vaccine. No other COVID-19 vaccines were included in the study, which was published online June 9 in the journal Nature Medicine.

The increased risk of ITP associated with the AstraZeneca vaccines is smaller than the risk of ITP caused by COVID-19, the researchers noted.

"This careful analysis of an entire country's vaccination program, which involved the study of over 2.5 million first-dose vaccines, has found a small increase in the risk of ITP, clotting and bleeding events following the Oxford-AstraZeneca vaccine," said study co-author Aziz Sheikh, director of the University of Edinburgh's Usher Institute.

"This very small risk is important, but needs to be seen within the context of the very clear benefits of the vaccines and potentially higher risks of these outcomes in those who develop COVID-19," Sheikh added in a university news release.

"Reassuringly, we did not identify any overall increased risk of ITP, clotting and bleeding events in those receiving the Pfizer-BioNTech mRNA vaccine. We are now planning to update our analysis as the vaccine program is being extended to younger, healthier individuals and as new vaccines are becoming available," said study lead author Colin Simpson, a professor at Victoria University of Wellington in New Zealand.

More information

The U.S. National Institutes of Health has more on ITP.

SOURCE: University of Edinburgh, news release, June 9, 2021




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net